
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
A REVIEW ARTICLE OF TELMISARTAN IN THE TREATMENT OF HYPERTENSION
Ayasha Parveen* and Prof. (Dr) S.S Agarawal
Abstract Measurement of blood pressure in the clinic may provide a false impression of blood pressure control. Ambulatory blood pressure monitoring (ABPM) allows the automatic recording of the circadian variation in blood pressure and evaluation of the efficacy of antihypertensive medication throughout the dosing interval. Ambulatory blood pressure provides more effective prediction of cardiovascular risk; blood pressure control at the time of heightened risk. Telmisartan, an angiotensin II receptor blocker, as well as having a terminal elimination half life of 24hrs, has a large volume of distribution due to its high lipophilicity. Telmisartan comes under the class of angiotensin receptor blockers (ARBs) and it is used for the treatment of high blood pressure, it reduces the risk of heart attack, stroke, or death from cardiovascular diseases, it is an angiotensin II receptor antagonist (ARB) that was used in the management of hypertension. Keywords: Angiotensin II receptor blocker, antihypertensive, cardiovascular disease, hypertension and telmisartan. [Full Text Article] [Download Certificate] |
